AgomAb Therapeutics NV American Depositary Shares (AGMB)

AgomAb Therapeutics NV American Depositary Shares (AGMB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $422M; returns 1 day -2.3%, 1 week +9.3%.

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing disease-modifying therapies for chronic fibrotic and inflammatory diseases. The company's primary focus is on the TGFβ and HGF/MET signaling pathways.

Groups AGMB belongs to

• Recent IPOs
• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Chronic Inflammatory Diseases
• Fibrosis
• Healthcare
• Life Sciences
• Gastroenterology
• Clinical Stage Biopharma
• Unmet Medical Needs
• Antibody Therapeutics
• Regenerative Medicine

AGMB financial model: income statement, cash flow and balance sheet